The CardioVascular Interventions Summit 2024 is proud to spotlight Dr. William O’Neill, MD, FACC, MSCAI, a luminary in the field of interventional cardiology, as a distinguished faculty member.

Dr. O’Neill’s career is defined by groundbreaking advancements and an unwavering pursuit of improving patient outcomes. As one of the Master Fellows of the Society for Cardiovascular Angiography and Interventions (MSCAI) and a pivotal figure in the development of angioplasty for heart attack treatment, his work has set the standard for cardiac care globally.

Transformative Impact

Dr. O’Neill has also led the charge in catheter-based treatments of structural heart disease, notably performing the first transcaval aortic valve replacement (TAVR) in the U.S. in 2005. His leadership in the Detroit Cardiogenic Shock Initiative has notably increased survival rates from massive heart attacks.

With over 450 peer-reviewed articles and abstracts, Dr. O’Neill’s contributions to medical publications is extensive. His role in shaping the next generation of cardiologists, combined with his tenure in prestigious academic and teaching hospitals, underscores his dedication to advancing the field of cardiology.

Awards and Recognition

Dr. O’Neill’s career is full with accolades, including America’s Top Doctors and the Transcatheter Cardiovascular Therapeutics Lifetime Achievement Award. His foundational work with the American Board of Internal Medicine interventional cardiology board and the American College of Cardiology highlights his influence on the profession.

As we approach CVIS 2024, we eagerly anticipate the wisdom and insights Dr. O’Neill will share. Join us at CVIS 2024 to celebrate Dr. William O’Neill’s unparalleled contributions to cardiology. His legacy of innovation, education, and patient care continues to light the way for a healthier world. 

Stay tuned and follow CVISummit for more information and announcements.